Hepatitis B vaccination after liver transplantation
β Scribed by Alberto Sanchez-Fueyo; Eva Martinez-Bauer; Antoni Rimola
- Book ID
- 111721900
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 57 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## To the Editors: De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and eco
Patients who undergo transplantation for hepatitis B virus (HBV)-related diseases are treated indefinitely with hepatitis B hyperimmunoglobulin (HBIG) to prevent endogenous HBV reinfection of the graft. Active immunization with standard hepatitis B vaccines in these patients has recently been report
It is a common practice to immunize patients against hepatitis B infection while they are waiting for liver transplantation, but the efficacy of this practice is unclear. This is a retrospective analysis of the antibody response to 20 microg of a recombinant hepatitis B vaccine in patients waiting f
Hepatitis B vaccination after liver transplantation for hepatitis B-related liver disease has been investigated as an alternative strategy to reinfection prophylaxis with hepatitis B immunoglobulin (HBIG) with conflicting results. In most studies, HBIG treatment was discontinued before vaccination.